Angioimmunoblastic T-cell lymphoma and hypereosinophilic syndrome with FIP1L1/PDGFRA fusion gene effectively treated with imatinib: A case report

RATIONALE: Hypereosinophilic syndrome (HES) is a rare disorder characterized by hypereosinophilia and organ damage. Some cases of HES are caused by the FIP1L1/PDGFRA fusion gene and respond to imatinib. FIP1L1/PDGFRA-positive HES occasionally evolves into chronic eosinophilic leukemia or into anothe...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamamoto, Masayo, Ikuta, Katsuya, Toki, Yasumichi, Hatayama, Mayumi, Shindo, Motohiro, Torimoto, Yoshihiro, Okumura, Toshikatsu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6392760/
https://www.ncbi.nlm.nih.gov/pubmed/28885361
http://dx.doi.org/10.1097/MD.0000000000008001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6392760/
https://www.ncbi.nlm.nih.gov/pubmed/28885361
http://dx.doi.org/10.1097/MD.0000000000008001

Ejemplares similares